Skip to main content

CORRECTION article

Front. Pharmacol., 21 November 2022
Sec. Cardiovascular and Smooth Muscle Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1080645
This article is part of the Research Topic Molecular Mechanism and Pharmacology of Metabolism and Cardiac Remodeling View all 9 articles

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities

This article is a correction to:

  1. Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities

    1. Read original article
Jun ZhangJun Zhang1Zunyuan YangZunyuan Yang2Xue JiaXue Jia3Xinxin LiXinxin Li1Xiangyang WangXiangyang Wang1Hua RongHua Rong1Yinan LiangYinan Liang2Wen ZengWen Zeng2Wei Jia, Wei Jia4,5*Xiaohui Ma Xiaohui Ma1*
  • 1The State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd, Tianjin, China
  • 2PriMed Non-Human Primate Research Center of Sichuan PriMed Shines Bio-Tech Co., Ltd., Ya’an, Sichuan, China
  • 3China Pharmaceutical University, Nanjing, China
  • 4Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
  • 5School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China

A Corrigendum on
Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities

by Zhang J, Yang Z, Jia X, Li X, Wang X, Rong H, Liang Y, Zeng W, Jia W and Ma X (2022). Front. Pharmacol. 13:1017433. doi: 10.3389/fphar.2022.1017433

In the original article, there was an error in the name of Traditional Chinese Medicine throughout the article. The name was displayed as “QiShenYiQi Dripping Pills (T101)” or “QSYQ (T101)”. The corrected name is “QiShenYiQi Dripping Pills” or “QSYQ”. The code number T101 has been deleted in the title and Figure 1.

FIGURE 1
www.frontiersin.org

FIGURE 1. The flowchart of the study.

The corrected title appears below.

“Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities”.

The corrected Figure 1 and its caption “The flowchart of the study.” appear below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: heart failure, QSYQ, SHR, network pharmacology, metabolomics

Citation: Zhang J, Yang Z, Jia X, Li X, Wang X, Rong H, Liang Y, Zeng W, Jia W and Ma X (2022) Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities. Front. Pharmacol. 13:1080645. doi: 10.3389/fphar.2022.1080645

Received: 26 October 2022; Accepted: 04 November 2022;
Published: 21 November 2022.

Edited and reviewed by:

Wei Deng, Renmin Hospital of Wuhan University, China

Copyright © 2022 Zhang, Yang, Jia, Li, Wang, Rong, Liang, Zeng, Jia and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wei Jia, d2VpamlhMUBoa2J1LmVkdS5oaw==; Xiaohui Ma, bWF4aWFvaHVpQHRhc2x5LmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.